221 related articles for article (PubMed ID: 18642640)
1. Transgenic rodent models of Parkinson's disease.
Harvey BK; Wang Y; Hoffer BJ
Acta Neurochir Suppl; 2008; 101():89-92. PubMed ID: 18642640
[TBL] [Abstract][Full Text] [Related]
2. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
Büeler H
Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of Pink1 gene in vivo sensitizes dopamine-producing neurons to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and can be rescued by autosomal recessive Parkinson disease genes, Parkin or DJ-1.
Haque ME; Mount MP; Safarpour F; Abdel-Messih E; Callaghan S; Mazerolle C; Kitada T; Slack RS; Wallace V; Shen J; Anisman H; Park DS
J Biol Chem; 2012 Jun; 287(27):23162-70. PubMed ID: 22511790
[TBL] [Abstract][Full Text] [Related]
4. What genetics tells us about the causes and mechanisms of Parkinson's disease.
Corti O; Lesage S; Brice A
Physiol Rev; 2011 Oct; 91(4):1161-218. PubMed ID: 22013209
[TBL] [Abstract][Full Text] [Related]
5. α-Synuclein transgenic mice reveal compensatory increases in Parkinson's disease-associated proteins DJ-1 and parkin and have enhanced α-synuclein and PINK1 levels after rotenone treatment.
George S; Mok SS; Nurjono M; Ayton S; Finkelstein DI; Masters CL; Li QX; Culvenor JG
J Mol Neurosci; 2010 Oct; 42(2):243-54. PubMed ID: 20464527
[TBL] [Abstract][Full Text] [Related]
6. Surprising behavioral and neurochemical enhancements in mice with combined mutations linked to Parkinson's disease.
Hennis MR; Marvin MA; Taylor CM; Goldberg MS
Neurobiol Dis; 2014 Feb; 62():113-23. PubMed ID: 24075852
[TBL] [Abstract][Full Text] [Related]
7. Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinson's disease.
Yonova-Doing E; Atadzhanov M; Quadri M; Kelly P; Shawa N; Musonda ST; Simons EJ; Breedveld GJ; Oostra BA; Bonifati V
Parkinsonism Relat Disord; 2012 Jun; 18(5):567-71. PubMed ID: 22445250
[TBL] [Abstract][Full Text] [Related]
8. [Molecular biology for familial Parkinson's disease].
Shiba K; Hattori N
Nihon Rinsho; 2004 Sep; 62(9):1617-22. PubMed ID: 15462374
[TBL] [Abstract][Full Text] [Related]
9. Parkinson's disease.
Thomas B; Beal MF
Hum Mol Genet; 2007 Oct; 16 Spec No. 2():R183-94. PubMed ID: 17911161
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a common biological pathway linking three Parkinson's disease-causing genes: parkin, PINK1 and DJ-1.
van der Merwe C; Jalali Sefid Dashti Z; Christoffels A; Loos B; Bardien S
Eur J Neurosci; 2015 May; 41(9):1113-25. PubMed ID: 25761903
[TBL] [Abstract][Full Text] [Related]
11. The MitoPark Mouse - an animal model of Parkinson's disease with impaired respiratory chain function in dopamine neurons.
Ekstrand MI; Galter D
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S185-8. PubMed ID: 20082987
[TBL] [Abstract][Full Text] [Related]
12. Dopaminergic Neurons Exhibit an Age-Dependent Decline in Electrophysiological Parameters in the MitoPark Mouse Model of Parkinson's Disease.
Branch SY; Chen C; Sharma R; Lechleiter JD; Li S; Beckstead MJ
J Neurosci; 2016 Apr; 36(14):4026-37. PubMed ID: 27053209
[TBL] [Abstract][Full Text] [Related]
13. [Parkin and mitochondria].
Mitsui T; Kuroda Y; Kaji R
Brain Nerve; 2008 Aug; 60(8):923-9. PubMed ID: 18717196
[TBL] [Abstract][Full Text] [Related]
14. Genetic factors involved in the pathogenesis of Parkinson's disease.
Lee FJ; Liu F
Brain Res Rev; 2008 Aug; 58(2):354-64. PubMed ID: 18313759
[TBL] [Abstract][Full Text] [Related]
15. Characterization of nonmotor behavioral impairments and their neurochemical mechanisms in the MitoPark mouse model of progressive neurodegeneration in Parkinson's disease.
Langley MR; Ghaisas S; Palanisamy BN; Ay M; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
Exp Neurol; 2021 Jul; 341():113716. PubMed ID: 33839143
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of Parkinson's disease-associated genes in mice reveals altered survival and bioenergetics of Parkin-deficient dopamine neurons.
Giguère N; Pacelli C; Saumure C; Bourque MJ; Matheoud D; Levesque D; Slack RS; Park DS; Trudeau LÉ
J Biol Chem; 2018 Jun; 293(25):9580-9593. PubMed ID: 29700116
[TBL] [Abstract][Full Text] [Related]
17. Is there a pathogenic role for mitochondria in Parkinson's disease?
Vives-Bauza C; de Vries RL; Tocilescu MA; Przedborski S
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S241-4. PubMed ID: 20083000
[TBL] [Abstract][Full Text] [Related]
18. Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease.
Dodson MW; Guo M
Curr Opin Neurobiol; 2007 Jun; 17(3):331-7. PubMed ID: 17499497
[TBL] [Abstract][Full Text] [Related]
19. The paths to neurodegeneration in genetic Parkinson's disease.
Abdel-Salam OM
CNS Neurol Disord Drug Targets; 2014; 13(9):1485-512. PubMed ID: 25106632
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms underlying protective effects of quercetin against mitochondrial dysfunction and progressive dopaminergic neurodegeneration in cell culture and MitoPark transgenic mouse models of Parkinson's Disease.
Ay M; Luo J; Langley M; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
J Neurochem; 2017 Jun; 141(5):766-782. PubMed ID: 28376279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
